세계의 종양학 영상 인공지능(AI) 시장

Oncology is where medical imaging AI is being tested most aggressively-and where it is starting to stick. Breast and lung screening programs, complex CT/MRI staging, PET-based theranostics, and RT planning are all pushing clinicians toward faster, more consistent, more quantitative imaging decisions.

This Markintel(TM) Horizon report quantifies and explains that shift. It analyzes the World Market for Oncology Imaging AI from 2023 to 2032, using a consistent segmentation across:

• Modality: CT, X-ray/DR (incl. DBT), MRI, PET/Nuclear, Ultrasound
• Tumor site: Breast, Lung/Chest, Prostate, Colorectal, Liver, Neuro-oncology, and others
• Clinical application & pathway stage: from Screening & Risk through Treatment Planning and Response
• Revenue stream & buyer type: Hardware attach, Software, Services, Cloud/PPU across Cancer Centers, IDNs/AMCs, Community providers, and Teleradiology

Beyond the numbers, the report applies the full Markintel framework stack-M3, ARC-Index, GTM Growth-Maturity, and the new Upgrade & Package Ladders-to show how AI Software vendors, Imaging OEMs, RT planning providers, AI Platforms, Providers/Telerad networks, and Imaging-Pharma/CROs can convert opportunity into repeatable, profitable business.

The goal is not just to describe the market, but to give executives an insights-to-action playbook: where Oncology Imaging AI is truly ready to scale, which clusters will capture the value, and what evidence, packaging, and partnerships will matter most over the next three to five years.

Market Snapshot

Oncology Imaging AI has moved from experimental pilots to a fast scaling market. The report sizes a global opportunity that expands more than 10x between 2023 and 2032, with a compound annual growth rate in the low 30s. North America remains the largest revenue pool over the horizon, but Asia-Pacific is the fastest growing region, overtaking Europe on momentum as national breast and lung programs, domestic OEMs, and cloud first deployments ramp. Europe stays a strong second engine, with adoption paced by MDR, HTA, and national screening strategies.

Most spend concentrates in CT, X ray/DBT and MRI oncology workflows, with PET/Nuclear and Ultrasound forming smaller but high value niches tied to theranostics, quantification, and interventional oncology. The mix of value pools also shifts along the pathway: Detection & Diagnosis remains foundational, but more spend migrates toward screening, treatment planning, and response assessment, where lesion level segmentation, dosimetry, and structured reporting are becoming mandatory for modern cancer programs.

The report quantifies Oncology Imaging AI across regions and countries, modalities, tumor sites, clinical applications, pathway stages, revenue streams, and end use settings (cancer centers, IDNs/AMCs, community providers, teleradiology). Detailed numbers are reserved for report buyers; the public snapshot is directional by design.

What's Covered:

• Global market sizing & forecast (2023-2032) - total Oncology Imaging AI market today and through 2032, with growth outlook, scenario commentary and key inflection points along the decade.
• Granular segmentation of value pools - analysis by modality, tumor site, clinical application, pathway stage, revenue stream and end-use setting (cancer centers, IDNs/AMCs, community hospitals, imaging centers, teleradiology), aligned with the broader Markintel(TM) AI-in-Imaging taxonomy.
• Regional & country perspectives - detailed views for North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, including commentary on leading and fast-growth countries, screening initiatives, and local regulatory/reimbursement dynamics.
• Clinical & technology trends across the oncology pathway - how AI is being deployed from breast and lung screening through CT/MR staging, RT planning, PET theranostics and longitudinal response assessment, with use-case mapping to Screening, Diagnosis, Staging, Planning, Response and Surveillance stages.
• Regulatory, reimbursement and evidence landscape (ARC) - assessment of Approvals, Reimbursement and Clinical validation by key use case (e.g., DBT AI, CT-lung, adaptive RT, PET response, radiomics), including where Oncology Imaging AI is deployment-ready vs where it remains pilot-only.
• Competitive landscape by cluster - analysis of six major competitive clusters (AI Software, Imaging OEMs, RT/TPS vendors, AI Platforms & Cloud, Providers & Teleradiology, Imaging-Pharma/CRO & Trials), with GTM Growth-Maturity positioning and qualitative company spotlights.
• GTM & packaging strategies - Markintel Upgrade & Package Ladders for each cluster (Foundation / Advanced / Elite), recommended commercial and pricing rules, channel and partnership strategies, and implications for attach-rate expansion and suite-based selling.
• Strategic implications & scenarios - cross-cutting insights on where Oncology Imaging AI is likely to become "workflow-critical infrastructure," how APAC's faster growth changes global competition, and what boards, product leaders and investors should prioritize over the next 3-5 years.

Companies Covered:

The list is cluster balanced-it includes AI software specialists, modality OEMs, RT/TPS vendors, platform players, provider/telerad networks, and imaging pharma/iCROs that feature in the oncology analysis.

TABLE OF CONTENTS

SECTION 1 - EXECUTIVE SUMMARY

Why This Market Matters - The 25-Second Read

Global Growth at A Glance (2023-2032)

Where Along the Pathway the Money Is Moving

Global Market Drivers & Restraints

• Key Growth Drivers
• Structural Restraints

Regional Pulse - Who Leads, Who Accelerates

• North America
• Asia-Pacific
• Europe
• LATAM & MEA

Five Strategy Headlines to Internalize

Structural Shifts by Modality, Application, Pathway, And End-Use

Competitive Architecture and Vendor Clusters

Three-Year KPI Outlook (2025-2027) & Board-Level Actions

• Three-Year KPI Outlook
• Actions For Vendors Over the Next 12 Months

SECTION 2 - RESEARCH METHODOLOGY

About This Report

Scope & Segmentation - What is Being Measured

• Segmentation Axes

Dual-Lens Architecture - How Numbers Are Built

Top-Down Market Funnel - Anchoring the Oncology Slice

Bottom-Up Attach-Rate Flow - How Oncology Revenue Actually Accrues

Evidence Confidence - How We Weight and Quality-Check Inputs

Framework Stack - Why the Numbers Are Actionable

Company Coverage, GTM Growth-Maturity & Competitive Datasets

• Company Universe And Clustering
• GTM Growth-Maturity Quadrants
• Competitive Dataset Tables
• Evidence Confidence

Upgrade & Package Ladders

• Definition
• Default Commercial Rules

Cluster-Based Competitive Architecture & Market Segment Bridging

• Clusters (Roles)
• Global Cluster<->Segment Bridge

Quality Assurance, Limitations, And Scenario Handling

SECTION 3 - STRATEGIC ANALYSIS & FRAMEWORKS

AI SOFTWARE CLUSTER

• Markintel M3 - Market Momentum Matrix (AI Software Key Sub-Segments)
  • How to Read This Matrix
• Markintel ARC Framework - Oncology Use Cases Addressable by AI Software Lens
  • Markintel ARC Grid - AI Software (Oncology Imaging AI)
  • How to Read This Exhibit
  • ARC-Index by Segment - AI Software (Oncology Imaging AI)
  • ARC -> Upgrade Ladder Mapping - AI Software
  • Recommendations (AI Software Vendors)
• Markintel GTM Growth-Maturity Matrix - AI Software Vendors (Oncology Imaging AI)
  • How To Read This Matrix
  • Competitive Dataset - AI Software - Oncology Imaging AI
  • Company Scoreboard - AI Software - Oncology Imaging AI
  • AI Software - Market Segmentation Bridge
• Markintel Upgrade & Package Ladder - AI Software (Oncology Imaging AI)
  • Objective
  • Upgrade Ladder Structure - AI Software (Oncology) Packages
  • Target Customers & Package Composition - AI Software - Oncology Upgrade & Package Ladder
  • Recommended Commercial Rules - AI Software (Oncology)
• Company Spotlights - AI Software Cluster
  • Aidoc
  • AIQ Solutions
  • Koios Medical
  • Lunit
  • Median Technologies
  • Quibim
  • QView Medical
  • RadNet / DeepHealth
  • Riverain Technologies
  • ScreenPoint Medical (Transpara)
  • Therapixel (MammoScreen)
  • Vara

IMAGING OEMs CLUSTER (ONCOLOGY ATTACH & AI SUITES)

• Markintel M3 - Market Momentum Matrix (Imaging OEMs Key Sub-Segments)
  • How to Read This Matrix
• Markintel ARC Framework - Oncology Imaging AI Use Cases Addressable by OEMs
  • Key OEM Oncology Segments
  • ARC Grid - Imaging OEMs
  • How to Read This Exhibit
  • ARC Table - Imaging OEMs (Oncology)
• Markintel GTM Growth-Maturity Matrix - Imaging OEMs (Oncology Imaging AI)
  • Competitive Dataset - Imaging OEMS - Oncology Imaging AI
  • How to Read this Matrix
  • Imaging OEMs Competitive Scoreboard - Oncology Imaging AI
  • Imaging OEMs Cluster - Oncology Imaging AI Market Segmentation Bridge
• Upgrade & Package Ladder - Imaging OEMs Lens (Oncology Imaging AI)
  • Objective
  • Ladder Structure - OEM Oncology Packages
  • Imaging OEMs - Oncology AI Upgrade & Package Ladder - Target Customers & Package Composition
  • Recommended Commercial Rules - OEM Oncology Cluster
• Company Spotlights - Imaging OEMs (Oncology Attach & AI Suites)
  • Canon Medical
  • Fujifilm Healthcare
  • GE HealthCare
  • Hologic
  • Philips Healthcare
  • Samsung Healthcare
  • Siemens Healthineers
  • United Imaging

RT / ONCOLOGY PLANNING CLUSTER (AUTO-CONTOUR, ADAPTIVE, DOSE/RESPONSE)

• Executive Summary
• Markintel M3 - Market Momentum Matrix of Key Subsegments (RT/Oncology Planning Lens)
  • What it Says (RT / Oncology Planning)
• Markintel ARC-Framework by Oncology Use Case (RT/Oncology Planning Lens)
  • ARC Grid - RT/Oncology Planning
  • ARC Table - RT / Oncology Planning
  • RT Recommendations
• Markintel GTM Growth-Maturity Matrix -- RT & Oncology Planning Vendors (Oncology Imaging AI)
  • Competitor Scoreboard
  • RT / Oncology Planning - Market Segmentation Bridge
• Markintel Upgrade & Package Ladder - RT / Oncology Planning
  • Objective
  • Ladder structure - RT / Oncology Planning packages
  • RT/Oncology Planning Cluster - Oncology AI Upgrade & Package Ladder - Target Customers & Package Composition
  • Recommended Commercial Rules - RT / Oncology Planning
• Company Spotlights - RT / Oncology Planning
  • Accuray
  • Brainlab
  • Elekta
  • Limbus AI
  • MIM Software
  • Mirada Medical
  • MVision AI
  • RaySearch Laboratories
  • Varian (Siemens)

AI PLATFORMS & CLOUD CLUSTER (NEUTRAL PLATFORMS, ORCHESTRATION, MARKETPLACES)

• Executive Summary
• Markintel M3 - Market Momentum Matrix (AI Platforms & Cloud Key Sub-Segments)
  • What it Says (AI Platforms & Cloud)
• Markintel ARC Framework - Oncology Use Cases Addressable by AI Platforms & Cloud
  • ARC Grid - AI Platforms & Cloud
  • ARC Table - AI Platforms & Cloud
• Markintel GTM Growth-Maturity Matrix - AI Platforms & Cloud Providers (Oncology Imaging AI)
  • Competitor Scoreboard
  • AI Platforms & Cloud - Market Segmentation Bridge
• Upgrade & Package Ladder - AI Platforms & Cloud (Oncology)
  • Objective
  • Ladder Structure - Platform & Cloud packages
  • AI Platforms & Cloud - Oncology Upgrade & Package Ladder - Oncology Imaging AI
  • Recommended Default commercial Rules - Platforms & Cloud
• Company Spotlights - AI Platforms & Cloud
  • CARPL.ai
  • deepc (deepcOS)
  • Ferrum Health
  • Incepto
  • Nuance Precision Imaging Network (PIN)
  • Tempus (Arterys)

PROVIDERS & TELERADIOLOGY CLUSTER (AI-ASSISTED SERVICES)

• Executive Summary
• Markintel M3 - Market Momentum Matrix (Providers & Teleradiology Key Subsegments)
  • What it Says (Providers & Telerad)
• Markintel ARC Framework - Oncology Use Cases Addressable by Providers & Teleradiology
  • ARC Grid - Providers & Teleradiology
  • ARC Table - Providers & Teleradiology
• GTM Growth-Maturity Matrix - Providers & Teleradiology Networks (Oncology Imaging AI)
  • Competitive Dataset - Services Rails, Governance, Oncology Footprint
  • Competitive Scoreboard
  • Providers & Teleradiology - Market Segmentation Bridge
• Markintel Upgrade & Package Ladder - Providers & Teleradiology (Oncology)
  • Objective
  • Ladder Structure - Oncology Service Packages
  • Providers & Teleradiology - Oncology Upgrade & Package Ladder - Target Customers & Package Composition
  • Recommended Default Commercial Rules - Providers & Teleradiology
• Company Spotlights - Providers & Teleradiology (AI-Assisted Services)
  • 5C Network
  • Everlight Radiology
  • DocPanel
  • RadNet / DeepHealth
  • Teleradiology Solutions
  • Unilabs / Telemedicine Clinic (TMC)
  • vRad

IMAGING-PHARMA / CRO & TRIALS CLUSTER (RADIOMICS, RESPONSE, THERANOSTICS)

• Executive Summary
• Markintel M3 - Market Momentum Matrix (Imaging-Pharma / CRO & Trials Key Sub-Segments)
  • M3 Table - Imaging-Pharma / CRO & Trials
• Markintel ARC Framework - Oncology Imaging AI Use Cases Addressable by Imaging-Pharma / CRO & Trials
  • ARC Grid - Imaging-Pharma / CRO & Trials
  • ARC Table - Imaging-Pharma / CRO & Trials
• Markintel GTM Growth-Maturity Matrix - Imaging-Pharma & CROs (Oncology Imaging AI)
  • Competitive Dataset - endpoint standardization & clinic bridge
  • Competitor Scoreboard
  • Imaging-Pharma / CRO & Trials - Market Segmentation Bridge
• Upgrade & Package Ladder - Imaging-Pharma / CRO & Trials
  • Objective
  • Ladder Structure - Imaging-Pharma / CRO & Trials
  • Imaging-Pharma / CRO & Trials - Upgrade & Package Ladder - Target Customers and Package Composition
  • Recommended Default Commercial Rules - Imaging-Pharma / CRO & Trials
• Company Spotlights - Imaging-Pharma / CRO & Trials (Radiomics, Response, Theranostics)
  • AIQ Solutions
  • Bracco
  • Guerbet
  • Lantheus / EXINI (aPROMISE / PYLARIFY AI)
  • Median Technologies
  • Quibim

SECTION 4 - WORLD MARKET FOR ONCOLOGY IMAGING AI

WORLD MARKET OVERVIEW

• Oncology Imaging AI: From Niche App to Enterprise Platform
  • Why Adoption is Accelerating
• Regional Growth Snapshot (2023 -> 2032)
• Strategic Implications for Vendors
• Market Momentum & Outlook

WORLD MARKET FORECAST BY REGION (2023-2032)

WORLD MARKET BY COUNTRY x END-USE ORG

• Estimate by Country x End-Use (USD Mill, 2023)
• Forecast by Country x End-Use (2032)
• Highlights (2032 Country Pattern vs World Mix)
• What's Shifting vs 2023 (Directional)
• Top Growth Cells (US$ M Lift, 2023->2032)
• What This Means (Commercial Playbook)
• Signals to Watch

WORLD MARKET BY MODALITY

• Highlights
• World Market by Modality (2023-32)
  • Implications
• Market Math & Diffusion Pattern
  • 2032 Mix and Key Growth Lenses
  • Share Shift and Dollar Lift (2023 -> 2032)
• Competitive Landscape - by Modality
• Modality Deep-Dives (Oncology-specific)
  • CT
  • X-ray/DR (incl. Mammography)
  • MRI
  • PET/Nuclear
  • Ultrasound
• Strategic Takeaways for Vendors (Oncology-specific)
• Signals to Watch (2025-2027)

WORLD MARKET BY CLINICAL APPLICATION

• Highlights
• World Market by Clinical Application (2023-32)
• What's Shifting
• Key Growth Lenses by Application
• Who Contributes the Growth (2023->2032 lift)
• What This Means
• Competitive Landscape - by Clinical Application
• Deep Dives by Clinical Application
  • Detection & Diagnosis
  • Quantification & Analytics
  • Workflow & Orchestration
  • Reporting & Communication
  • Image Reconstruction & Acquisition
• Strategic Takeaways for Vendors
• Signals to Watch (2025-2027)

WORLD MARKET BY TUMOR SITE

• Highlights
• What's Shifting (Mix Dynamics)
• World Market by Tumor Site (2023-32)
• Growth Lenses - by Tumor Site
• What This Means
• What Shifts Through 2032
• Commercial Takeaways
• Competitive Landscape - by Tumor Site
• Deep Dives by Tumor Site
  • Breast
  • Lung/Chest
  • Prostate
  • Colorectal
  • Liver
  • Neuro-Oncology
  • Gynecologic
  • Head & Neck
  • Other (Rare)
• Strategic Takeaways
• Signals to Watch (2025-2027)

WORLD MARKET BY REVENUE STREAM

• Highlights
• What's Shifting
• World Market by Revenue Stream (2023-32)
• Growth Lenses - by Revenue Stream
• Who Contributes the Growth (2023->2032 Dollar Lift)
• What This Means
• Deep Dives by Revenue Stream
  • Hardware
  • Software
  • Service
  • Cloud/PPU
• Competitive Landscape - by Revenue Stream
• Signals to Watch (2025-2027)

WORLD MARKET BY END-USE ORGANIZATION TYPE

• Highlights
• What's Shifting
• World Market by End-Use Organization (2023-32)
• Growth Lenses by End-use
• Who Contributes the Growth (2023->2032 Dollar Lift)
• What this Means
• Deep Dives
  • Academic/IDNs
  • Comprehensive Cancer Centers
  • Community Hospitals & Imaging Centers
  • Teleradiology Providers
• Competitive Landscape - by End-Use
• Signals to Watch (2025-2027)

WORLD MARKET BY AI TECHNOLOGY

• Highlights
• What's Shifting
• World Market by AI Technology (2023-32)
• Growth Lenses - by AI Technology
• Who Contributes the Growth (2023->2032 Dollar Lift)
• What This Means
• Deep Dives by AI Technology (Oncology Lens)
• Competitive Landscape - by AI Technology
• Signals to Watch (2025-2027)

WORLD MARKET BY PATHWAY STAGE

• Highlights
• What's Shifting
• World Market by Pathway Stage (2023-32)
• Growth Lenses - by Pathway Stage
• Who Contributes the Growth (2023->2032 Dollar Lift)
• What This Means
• Competitive Landscape - by Pathway Stage
• Signals to Watch (2025-2027)

REGIONAL MIX & MOMENTUM - WORLD ONCOLOGY IMAGING AI

• Executive Takeaways
• Marke by Region x Modality
  • World Market by Region x Modality - 2023
  • World Market by Region x Modality - 2032
  • What's Shifting (Mix, 2032 Over/Under-index)
  • Who Contributes the Growth (2023->2032 Lift)
  • What This Means
• Market by Region x Revenue Stream
  • World Market by Region x Revenue Stream - 2023
  • World Market by Region x Revenue Stream - 2032
  • What's Shifting (Mix, 2032 Over/Under Index)
  • Who Contributes the Growth
  • What This Means
• Market by Region x Clinical Application
  • World Market by Region x Clinical Application - 2023
  • World Market by Region x Clinical Application - 2032
  • What's Shifting (Mix, 2032 Over/Under Index)
  • Who Contributes the Growth
  • What this Means
  • Competitive Snapshots (Illustrative)

DISEASE-DRIVEN DEMAND MAP - WORLD ONCOLOGY IMAGING AI

• Executive Takeaways
• Tumor Site x Modality
  • World Market by Tumor Site x Modality - 2023
  • World Market by Tumor Site x Modality - 2032
  • What's Shifting (2032 Mix vs Global)
  • Who Contributes the Growth (2023->2032 Dollar Lift)
  • What This Means
• Tumor Site x Clinical Application
  • World Market by Tumor Site x Clinical Application - 2023
  • What's Shifting (2032 Mix vs Global)
  • World Market by Tumor Site x Clinical Application - 2032
  • Who Contributes the Growth (2023->2032 Dollar Lift)
  • What this means
• Tumor Site x Revenue Stream
  • World Market by Tumor Site x Revenue Stream - 2023
  • World Market by Tumor Site x Revenue Stream - 2032
  • What's Shifting (2032 mix vs global)
  • Who Contributes the Growth (2023->2032 Dollar lift)
  • What This Means
• Competitive Snapshot (Illustrative, Oncology-focused)
• Signals to Watch

WORKFLOW ECONOMICS - WORLD ONCOLOGY IMAGING AI

• Modality x Revenue Stream
  • World Market by Modality x Revenue Stream - 2023
  • World Market by Modality x Revenue Stream - 20232
  • Highlights
  • What's Shifting (Mix & Over/Under-Index)
  • Who Contributes the Growth (2023->2032 Dollar Lift)
  • What This Means (Commercial Playbook)
  • Competitive Lens (Illustrative)
• Clinical Application x Revenue Stream
  • Highlights (2032 Pattern)
  • World Market by Clinical Application x Revenue Stream - 2023
  • World Market by Clinical Application x Revenue Stream - 2032
  • What's Shifting (2023 -> 2032)
  • Who Contributes the Growth (US$ M lift, 2023->2032)
  • What This Means (Commercial Playbook by Application)
  • Competitive Lens (Indicative, Non-exhaustive)
  • Pricing Archetypes That Clear Approvals (What Buyers Say "Yes" to)
  • Signals to Watch
  • Risks & Watchouts

PATHWAY STAGE ECONOMICS - WORLD ONCOLOGY IMAGING AI

• Pathway Stage x Revenue Stream
  • Highlights
  • World Market by Pathway Stage x Revenue Stream - 2023
  • World Market by Pathway Stage x Revenue Stream - 2032
  • What's Shifting (Mix vs Global)
  • Who Contributes the Growth (2023 -> 2032 Dollar Lift)
  • What This Means (Commercial Playbook)
  • Competitive Lens (Indicative)
  • Signals to Watch
• Pathway Stage x Modality - Where Each Stage Leans and Why
  • World Market by Pathway Stage x Modality - 2023
  • World Market by Pathway Stage x Modality - 2032
  • Highlights (2032 Pattern vs World Mix)
  • Where the Dollars Moved (2023 -> 2032)
  • Stage-specific Readouts (2032 Shares Inside Each Stage)
  • What This Means (Commercial Takeaways)
  • Competitive Lens (Illustrative, not Exhaustive)
  • Signals to Watch
• Pathway Stage x Clinical Application - How Workloads Drive Spend
  • World Market by Pathway Stage x Clinical Application - 2023
  • World Market by Pathway Stage x Clinical Application - 2032
  • Highlights (2032 Pattern vs World Mix)
  • Where the Dollars Moved (2023 -> 2032)
  • What This Means (Commercial Playbook)
  • Competitive Lens (Indicative)
  • Signals to Watch
• Pathway Stage x End-use - Who Buys What, and Where Growth Concentrates
  • World Context (2032 End-use Mix)
  • World Market by Pathway Stage x End-use - 2023
  • World Market by Pathway Stage x End-use - 2032
  • Highlights (2032 Pattern vs Global Mix)
  • Who Contributes the Growth (US$ M lift 2023->2032)
  • What This Means (Commercial Playbook by Stage)
  • Competitive Lens (Indicative, Non-exhaustive)
  • Signals to Watch
• Pathway Stage x AI Technology - How Capability Mix Shifts Across the Cancer Pathway
  • World Tech Mix
  • World Market for Pathway Stage x AI Technology - 2023
  • World Market for Pathway Stage x AI Technology - 2032
  • Highlights (2032 Pattern vs Global Mix)
  • Where the Dollars Moved (2023 -> 2032)
  • What This Means (Commercial Playbook)
  • Competitive Lens (indicative)
  • Signals to Watch

SECTION 5 - NORTH AMERICA

North America - Market Overview & Dynamics

• North America - Executive Summary
• Market Size - (Country Roll-up)
  • What's Moving the Market
  • Key Differences to Plan Around
  • Structure of Spend by Revenue Stream (NA)
  • End-Use Organizations (NA)
  • AI Technology (NA)
  • Pathway Stage (NA)
  • Strategic Implications (North America)
  • What to Watch (Leading Indicators)

Market Analysis & Estimates + Forecasts

• North America - Market by Modality
  • Forecast by Modality (USD Mill, 2023-32)
  • North America - Market Math & Diffusion (Modality)
  • What's Driving North America (Shared Signals)
  • Where the Growth Comes From
  • Buyer & Hosting Posture
  • Commercial Playbook (NA)
  • What's Common Across NA (Region-Level Truths)
  • Key Differences (U.S. vs Canada)
  • Competitive Lens (Indicative, NA-relevant)
  • Regulatory & Reimbursement Scenarios (What to Plan for)
  • Commercial Playbook (NA)
  • Signals to Watch (Leading Indicators)
  • Risks & Mitigations
  • 90-Day Action List
• North America - Market by Clinical Application
  • Forecast by Clinical Application (USD Mill, 2023-32)
  • Market Math & Diffusion - North America, Clinical Application
  • Headline Math
  • What's Common Across the Region
  • Where the U.S. and Canada Differ (and How to Win)
  • Who Drives the Growth
  • Pricing & Packaging
  • Competitive Lens (indicative)
  • Signals to Watch ('25-'28)
  • Risk Notes
• North America - Market by Tumor Site
  • Forecast by Tumor Site (USD Mill, 2023-32)
  • Growth Engines (What's Moving)
  • What's Shifting (Mix and Posture)
  • Buyer & Hosting Posture (Regional Commonalities vs. Differences)
  • Who Drives the Growth (by Tumor)
  • Pricing & Packaging
  • Signals to Watch ('25-'28)
  • Actionable Mix
  • Risks
• North America - Market by Revenue Stream
  • Forecast by Revenue Stream (USD Mill, 2023-32)
  • Headline Mix & Lift (US$M, 2023->2032)
  • What's Driving Spend Patterns
  • US vs Canada - Common Rails, Different Motions
  • Regulatory & Reimbursement Cues
  • Packaging & Pricing Posture
  • GTM by Stream
• North America - Market by End-Use Organization Type
  • Forecast by End-Use Organization Type (USD Mill, 2023-32)
  • Headlines
  • Where the Dollars Land by 2032
  • Country Split of the Lift ('23->'32)
  • Implications for Go-to-Market
• North America - Market by AI Technology
  • Forecast by AI Technology (USD Mill, 2023-32)
  • Headlines
  • Where the Dollars Land by 2032 (Share / CAGR / Lift)
  • Mix Shift (2023 -> 2032)
  • Country Split of Dollar-lift ('23->'32)
  • Implications for Go-to-Market
• North America - Market by Pathway Stage
  • Forecast by Pathway Stage (USD Mill, 2023-32)
  • Headlines
  • Where the Dollars Land by 2032 (Share / CAGR / Lift)
  • Mix Shift (2023 -> 2032)
  • Country Split of the Dollar-Lift ('23->'32)
  • Implications for Go-to-Market

SECTION 6 - UNITED STATES

US Market Overview and Dynamics

• Market Size Summary
• What's Driving the U.S. (Demand & Supply)
• Attach, Pricing & Adoption Posture
• Distribution Rails & OEM Effects
• Regulatory, Evidence & Reimbursement Posture (Practical)
• Buyer & Hosting Posture (What U.S. Committees Expect)
• Commercial Playbook (How to Win)
• Risks & Watch-outs
• U.S. Vendor & Channel Snapshot (indicative)
• United States - At-a-Glance
  • Key Numbers (2023->2032)
  • Three Takeaways

US Market Estimates & Forecasts

• US Market by Modality
  • Forecast by Modality (USD Mill, 2023-32)
  • Highlights
  • What's Shifting (2025->2029)
  • Market Math & Diffusion (United States, Modality)
  • Who Drives the Lift
  • Pricing & Packaging (How to Win)
  • Competitive Lens (Indicative)
  • Signals to Watch ('25-'28)
  • Risks
  • 90-day Playbook (US)
• US Market by Clinical Application
  • Forecast by Clinical Application (USD Mill, 2023-32)
  • Highlights
  • What's Shifting (2025->2029)
  • Who Drives the Growth ('23->'32 Dollar-lift)
  • Market Math & Diffusion (United States, Clinical Application)
  • Pricing & Packaging - How to Win
  • Competitive Lens (Indicative)
  • Signals to Watch ('25-'28)
  • Risks
• US Market by Tumor Site
  • Forecast by Tumor Site (USD Mill, 2023-32)
  • Highlights
  • Incidence & Screening Context (Indicative, US)
  • What's Shifting (2025->2029)
  • Who Drives the Growth ('23->'32 dollar-lift)
  • Market Math & Diffusion (United States, Tumor Site)
  • Pricing & Packaging - How to Win
  • Signals to Watch
• US Market by Revenue Stream
  • Forecast by Revenue Stream (USD Mill, 2023-32)
  • Highlights
  • What's Shifting (2025->2029)
  • Who Drives the Growth ('23->'32 dollar-lift)
  • Market Math & Diffusion (United States, Revenue Stream)
  • Pricing & Packaging - How to Win
  • Buyer & Hosting Posture (US Reality)
  • Signals to Watch
  • 90-day Playbook (Practical)
  • Competitive Lens (Indicative)
• US Market by End-Use Organization Type
  • Forecast by End-Use Organization (USD Mill, 2023-32)
  • Highlights
  • What's Shifting (2025->2029)
  • Who Drives the Growth ('23->'32 dollar-lift)
  • Market Math & Diffusion (United States, End-Use Org)
  • Pricing & Packaging - How to Win
  • Buyer & Hosting Posture (US)
  • Signals to Watch
  • 90-day Playbook
• US Market by AI Technology
  • Forecast by AI Technology (2023-32)
  • Highlights
  • What's Shifting (2025->2029)
  • Who Drives the Growth ('23->'32 dollar-lift)
  • Pricing & Packaging - How to Win
  • Market Math & Diffusion (United States, AI Technology)
  • Buyer & Hosting Posture (US)
  • Signals to Watch
  • 90-day Playbook
• US Market by Pathway Stage
  • Forecast by Pathway Stage (USD Mill, 2023-32)
  • Highlights
  • What's Shifting (2025->2029)
  • Market Math & Diffusion (United States, Pathway Stage)
  • Who Drives the Growth ('23->'32 dollar-lift)
  • Pricing & Packaging - How to Win
  • Buyer & Hosting Posture
  • Signals to Watch
  • 90-day Playbook

SECTION 7 - CANADA

• Market Overview & Dynamics (2023->2032)
  • Where the Growth is
  • What's Driving Canada
  • Commercial
• Canada - At a Glance
  • Key Numbers
  • 2032 Mix Snapshot (Steady State)
  • Where the Dollars Come From ('23->'32 Lift)
  • Three Takeaways
• Buyer & Hosting Posture (Canada)
• Incidence & Screening (Context Signals)
• Policy & Reimbursement Signals (Canada-specific)
• Provider Landscape Snapshot (indicative, oncology-heavy)
• Packaging & Pricing Realities (Canada)
• Evidence & Regulatory Notes (Canada-relevant)
• Competitive Landscape (Indicative Clusters)

Canada - Market Estimates & Forecasts (Canada)

• Canada - Market by Modality
  • Forecast by Modality (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Market Math & Diffusion (What's Doing the Lifting)
  • Who Contributes the Growth
  • What This Means (Commercial Playbook)
  • Competitive Lens (Indicative Clusters)
  • Signals to Watch
  • Risks & Watch-outs
• Canada - Market by Clinical Application
  • Forecast by Clinical Application (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Market Math & Diffusion (Canada, Clinical Application)
  • Who Contributes the Growth
  • What This Means (Commercial Playbook)
  • Packaging & Monetization Matrix (Canada)
  • Competitive Lens (Indicative Clusters)
  • Signals to Watch
  • Risks & Watch-outs
• Canada - Market by Tumor Site
  • Forecast by Tumor Site (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Market Math & Diffusion (Canada, Tumor Site)
  • Who Contributes the Growth
  • What This Means (Commercial Playbook)
  • Packaging & Monetization Matrix (by Tumor, Canada)
  • Competitive Lens (Indicative)
  • Signals to Watch
  • Risks & Watch-outs
• Canada - Market by Revenue Stream
  • Forecast by Revenue Stream (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Market Math & Diffusion (Canada, Revenue Stream)
  • Who Contributes the Growth
  • What This Means (Commercial Playbook)
  • Packaging & Monetization Guardrails (Canada)
  • Competitive Lens (Indicative)
  • Signals to Watch
  • Risks & Watch-outs
• Canada - Market by End-Use Organization Type (2023-32)
  • Forecast by End-Use Organization Type (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Market Math & Diffusion (Canada, End-Use Orgs)
  • What This Means (Commercial Playbook)
  • Packaging & Monetization Matrix - by Buyer Type (Canada)
  • Signals to Watch
  • Risks & Watch-outs
• Canada - Market by AI Technology (2023-32)
  • Forecast by AI Technology (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Market Math & Diffusion (Canada, AI Technology)
  • Who Contributes the Growth
  • What This Means (Commercial Playbook)
  • Packaging & Monetization Matrix (Canada)
  • Competitive Lens (Indicative)
  • Signals to Watch
  • Risks & Watch-outs
• Canada - Market by Pathway Stage
  • Forecast by Pathway Stage (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Market Math & Diffusion (Canada, Pathway Stages)
  • Who Contributes the Growth
  • What This Means (Commercial Playbook)
  • Packaging & Monetization Matrix (Canada)

SECTION 8 - EUROPE

Market Overview and Dynamics

• Headlines (Scale & Slope)
• What's Changing Around Access & Regulation
  • Reimbursement, Funding & Procurement (Where Money Comes From)
  • Clinical & Operational Proof Points (Confidence to Buy)
  • How the Money Splits
  • Buyer-side Patterns
  • Risks & Watch-outs
  • Go-to-Market Implications (Europe-wide)
  • 12-month Operating Plan (Minimum Viable)

Market Estimates & Forecasts

• Europe - Market by Modality
  • Forecast by Modality (USD Mill, 2023-32)
  • Headlines
  • Where the Dollars Land by 2032 (Europe Totals; rounded)
  • Source: Marketstrat Estimates & Forecast Model
  • Country Split of the Lift ('23->'32)
  • Growth vs. Scale (what the Bubble shows)
  • Mix-shift (2023 -> 2032)
  • Implications for Go-to-Market
• Europe - Market by Clinical Application
  • Forecast by Clinical Application (USD Mill, 2023-32)
  • Europe Totals by Clinical Application
  • Deeper Dive
  • Who Drives Each Application? (2032 Revenue Split Within Each Application)
  • Interpretation
  • Commercial Implications
• Europe - Market by Tumor Site
  • Forecast by Tumor Site (USD Mill, 2023-32)
  • Headlines
  • Regional Synthesis
  • Europe Totals by Tumor Site (Rolled-Up; Rounded)
  • Who Drives Each Site? (2032 revenue split within site)
  • Commercial Implications
• Europe - Market by Revenue Stream
  • Forecast by Revenue Stream (USD Mill, 2023-32)
  • Headlines
  • Structure of Spend (rolled-up, rounded)
  • What This Means
  • Commercial Moves
• Europe - Market by End-Use Organization Type
  • Forecast by End-Use Org Type (USD Mill, 2023-32)
  • Headlines
  • Regional Synthesis
  • Europe Totals by End-Use Org (Rolled-Up; Rounded)
  • Commercial Implications (Europe)
• Europe - Market by AI Technology
  • Forecast by Tumor Site (USD Mill, 2023-32)
  • Headlines (Europe - AI Technology)
  • Where the Growth Comes From (2023->2032 Lift)
  • Commercial Implications
• Market by Pathway Stage
  • Forecast by Pathway Stage (USD Mill, 2023-32)
  • Headlines
  • Regional Synthesis
  • Europe Pathway Stage Totals
  • Commercial Implications

SECTION 9 - GERMANY

Germany - Market Overview and Analysis

• Headlines
• What's Driving Germany (Why This Curve Is Steep)
• "So What" - GTM & Packaging for Germany
• Germany - At a Glance
  • Key Numbers
  • 2032 Mix Snapshot (steady state)
  • Where the Dollars Come From ('23->'32 Lift)
  • Three Takeaways
• Buyer & Hosting Posture (Germany)
• Incidence & Screening - Context Signals
• What To Watch (Germany)

Germany - Market Estimates & Forecasts

• Market by Modality
  • Forecast by Modality (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Market Math & Diffusion (Germany, Modality)
  • Who Contributes the Growth
  • Signals to Watch (Germany-Specific)
  • What This Means (Commercial Playbook)
  • Risks & Watch-outs
• Germany - Market Size by Clinical Application
  • Forecast by Clinical Application (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Market Math & Diffusion (Germany, Clinical Applications)
  • Who Contributes the Growth
  • What This Means (Commercial Playbook)
  • Competitive Lens (Indicative)
  • Signals to Watch (Germany)
  • Risks & Watch-outs
• Germany - Market by Tumor Site
  • Highlights
  • Forecast by Tumor Site (USD Mill, 2023-32)
  • What's Shifting
  • What This Means (Commercial Playbook)
  • Market Math & Diffusion (Germany, Tumor Site)
• Germany - Market by Revenue Stream
  • Forecast by Revenue Stream (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Market-Math & Diffusion (Germany, Revenue Streams)
  • Who Contributes the Growth
  • What This Means (Commercial Playbook)
  • Packaging & Monetization Guardrails (Germany)
  • Signals to Watch
  • Risks & Watch-outs
• Germany - Market by End-Use Organization Type
  • Forecast by End-Use Organization Type (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • What This Means (Commercial Playbook)
  • Market-Math & Diffusion (Germany, End-Use Orgs)
• Germany - Market by AI Technology
  • Forecast by AI Technology (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Market-Math & Diffusion (Germany, AI Technology)
  • What This Means (Commercial Playbook)
• Germany - Market by Pathway Stage
  • Forecast by Pathway Stage (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Market Math & Diffusion (Germany, Pathway Stages)
  • What This Means (Commercial Playbook)
  • Signals to Watch (Germany)
  • Risks & Watch-outs

SECTION 10 - FRANCE

Market Overview & Dynamics

• Headline Math
• What's Driving France
• France - At a Glance
  • Key Numbers
  • 2032 Mix Snapshot
  • Where the Dollars Come From ('23->'32 Lift)
  • Three Takeaways
• Buyer & Hosting Posture (What RFPs Expect)
• Incidence & Screening - Context Signals (France)
• Policy, Reimbursement & Data-Residency (France-specific)
• Provider Landscape Snapshot (Route-to-market)
  • Anchor Systems & Networks
  • Local AI Ecosystem Touchpoints
• Packaging & Pricing Realities (France)
  • Packaging Snapshot
• Evidence & Regulatory Notes
• Competitive Lens (Indicative, Oncology-Relevant in FR)
• "So What" for France (GTM)

France - Market Estimates & Forecasts

• France - Market by Modality
  • Forecast by Modality (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Market-Math & Diffusion (France, Modality)
  • ho Contributes the Growth
  • What This Means (Commercial Playbook)
  • Competitive Lens (Indicative Clusters)
  • Signals to Watch (France-specific)
  • Risks & Watch-outs
• France - Market by Clinical Application
  • Forecast by Clinical Application (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Market-Math & Diffusion (France, Clinical Applications)
  • Who Contributes the Growth
  • What This Means (Commercial Playbook)
  • Competitive Lens (indicative clusters)
  • Signals to Watch (France)
  • Risks & Watch-outs
• France - Market by Tumor Site (2023-32)
  • Forecast by Tumor Site (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Market-Math & Diffusion (France, Tumor Site)
  • What This Means (Commercial Playbook)
  • Signals to Watch
  • Risks & Watch-outs
• France - Market by Revenue Stream
  • Forecast by Revenue Stream (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Market-Math & Diffusion (France, Revenue Streams)
  • Who Contributes the Growth
  • What This Means (Commercial Playbook)
  • Signals to Watch
  • Risks & Watch-outs
• France - Market by End-Use Organization Type
  • Forecast by End-Use Organization Type
  • Highlights
  • What's Shifting
  • What This Means (Commercial Playbook)
  • Market-Math & Diffusion (France, End-Use Orgs)
• France - Market by AI Technology
  • Forecast by AI Technology (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Market-Math & Diffusion (France, AI Technology)
  • Commercial Playbook (France)
• France - Market by Pathway Stage
  • Forecast by Pathway Stage (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • What This Means (Commercial Playbook)
  • Market-Math & Diffusion (France, Pathway Stages)

SECTION 11 - UNITED KINGDOM

UK - Market Overview & Dynamics

• Headline Math
• What's Driving the UK
  • Demand & Supply Fundamentals
  • Screening Rails Moving Upstream
  • Adoption Enablers
• So What (Commercial Playbook)
• United Kingdom - At a Glance
  • Key Numbers (2023->2032)
  • Three Takeaways
  • Buyer & Hosting Posture (UK-specific)
  • GTM Cue
• Incidence & Screening - Quick Context
• Policy, Reimbursement & Governance Signals (UK-Specific)
• Provider Landscape Snapshot (Indicative, GTM-relevant)
• Packaging & Pricing Realities (UK)
• Evidence & Regulatory Notes (what buyers will ask)
• Signals to Watch ('25-'28)
• Competitive Lens (indicative, UK-relevant clusters)

UK - Market Estimates & Forecasts

• UK - Market by Modality
  • Forecast by Modality (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Market Math & Diffusion (UK, Modality)
  • Who Contributes the Growth
  • What This Means (Commercial Playbook)
  • Signals to Watch (Execution)
  • Risks & Watch-outs
• UK - Market by Clinical Application
  • Forecast by Clinical Application (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Market Math & Diffusion (UK, Clinical Applications)
  • Commercial Playbook
• UK - Market by Tumor Site
  • Forecast by Tumor Site (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Market Math & Diffusion (UK, Tumor Site)
• UK - Market by Revenue Stream
  • Forecast by Revenue Stream (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Market Math & Diffusion (UK, Revenue Streams)
  • Commercial Playbook (UK)
• UK - Market by End-Use Organization Type
• Forecast by End-Use Org Type (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Market Math & Diffusion (UK, End-Use Orgs)
• UK - Market by AI Technology
  • Forecast by AI Technology (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Market Math & Diffusion (UK, AI Technology)
• UK - Market by Pathway Stage
  • Forecast by Pathway Stage (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Market Math & Diffusion (UK, Pathway Stage)

SECTION 12 - ITALY

Italy - Market Overview and Dynamics

• Italy - Headline Math (2023->2032)
• What's Driving Italy (why the curve is steep)
• "So What" - Commercial Playbook (how to win)
• Italy - At a Glance
  • Key Numbers
  • Three Takeaways
  • Where the Growth Comes From (Dollar Lift 2023->2032)
  • Buyer & Hosting Posture (Italy)
  • Packaging & Pricing Cues
  • Risks & Watch-outs
  • What to Do Next (Italy)
• Incidence & Screening - Context Signals (Why Oncology AI Is a Priority)
• Policy, Reimbursement & Governance (what can accelerate/slow deals)
• Provider Landscape Snapshot (Indicative GTM Targets)
• Packaging & Pricing Realities (Italy-specific)
• Evidence & Regulatory Notes
• Signals to Watch (Next 12-24 months)

Italy - Market Estimates & Forecasts

• Italy - Market by Modality
  • Forecast by Modality (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Market-Math & Diffusion (Italy, Modality)
  • Commercial Playbook (Italy)
  • Risks & Watch-outs
• Italy - Market by Clinical Application
  • Forecast by Clinical Application (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Market Math & Diffusion (Italy, Clinical Applications)
• Italy - Market by Tumor Site
  • Forecast by Tumor Site (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Market Math & Diffusion (Italy, Tumor Site)
  • Commercial Playbook (Tumor-site lens)
• Italy - Market by Revenue Stream
  • Forecast by Revenue Stream (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Market Math & Diffusion (Italy, Revenue Streams)
• Italy - Market by End-Use Organization Type (2023-32)
  • Forecast by End-Use Organization Type (USD Mill, 2023-32)
  • Highlights
  • What's Shifting (So-What)
  • Market Math & Diffusion (Italy, End-Use Orgs)
• Italy - Market by AI Technology
  • Forecast by AI Technology (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Market Math & Diffusion (Italy, AI Technology)
• Italy - Market by Pathway Stage
  • Forecast by Pathway Stage (USD Mill, 2023-32)
  • Highlights
  • What's Shifting (So-What)
  • Market Math & Diffusion (Italy, Pathway Stage)

SECTION 13 - REST OF EUROPE

Market Overview and Analysis

• Headline Math (ROE)
• Regional Clusters & Indicative Split
• Rest of Europe (ROE) - At a Glance
  • Key Numbers (2023->2032)
  • Three Takeaways
  • Buyer & Hosting Posture (ROE)
  • GTM Cue
• What's Driving Each Cluster
  • Spain
  • BENELUX
  • Nordics
  • Eastern Europe
• Buyer Archetypes & Hosting Posture (by Cluster)
• Modality & Pathway Tilt
• Packaging & Pricing Guidance (ROE)
• Channel Strategy by Cluster
• "So What" for Execution
• Signals to Watch
• Risks & Watch-outs

ROE - Market Estimates & Forecasts

• ROE - Market by Modality
  • Forecast by Modality (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Commercial Playbook
  • Market Math & Diffusion (ROE, Modality)
• Market by Clinical Application
  • Forecast by Clinical Application (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Market Math & Diffusion (ROE, Clinical Application)
• ROE - Market by Tumor Site
  • Forecast by Tumor Site (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Commercial Playbook
  • Market-Math & Diffusion (ROE, Tumor Site)
• ROE - Market by Revenue Stream
  • Forecast by Revenue Stream (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Commercial Playbook
  • Market-Math & Diffusion (ROE, Revenue Stream)
• ROE - Market by End-Use Organization Type
  • Forecast by End-Use Organization Type (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Commercial Playbook
  • Market-Math & Diffusion (ROE, End-Use Orgs)
• Market by AI Technology
  • Forecast by AI Technology (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Commercial Playbook
  • Market-Math & Diffusion (ROE, AI Technology)
• Market by Pathway Stage
  • Forecast by Pathway Stage (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Commercial Playbook
  • Market-Math & Diffusion (ROE, Pathway Stage)

SECTION 14 - ASIA-PACIFIC (APAC)

APAC Market Overview and Dynamics

• Headlines
• What's Driving the Step-Up (Pan-Regional)
• Market Structure & Mix (What the Numbers Imply)
• Regulatory & Reimbursement Snapshot (Operator's View)
• Data Governance (Deployment Constraint & Design Choice)
• State Of Market Evolution (2025-2029 -> 2030-2032)
• Commercial Implications & Plays
• Risks & Watch-Outs (And How to Mitigate)
• What Good Looks Like (Operating Blueprint)

APAC - Market Estimates & Forecasts

• APAC - Market by Modality
  • Forecast by Modality (USD Mill, 2023-32)
  • Headlines
  • What's Driving Growth (Beyond the Spreadsheets)
  • Modality Math (APAC Roll-Up; Rounded)
  • Where the Dollars Arise (Illustrative 2032 Splits by Modality)
  • Regulatory & Market-Access Cues to Watch
  • Commercial Implications
• APAC - Market by Clinical Application
  • Forecast by Clinical Application (USD Mill, 2023-32)
  • Headlines
  • Regional Synthesis
  • APAC Totals by Clinical Application (Rolled-Up; Rounded)
  • Who Drives Each Application? (2032 Revenue Split Within Application)
  • Commercial Implications
• APAC - Market by Tumor Site
  • Forecast by Tumor Site (USD Mill, 2023-32)
  • Headlines
  • Regional Synthesis
  • Who Leads by Country/Site (2032)
  • Commercial Implications
• APAC - Market by Revenue Stream
  • Forecast by Revenue Stream (USD Mill, 2023-32)
  • Headlines
  • Where the Dollar-Lift Comes From (2023->2032)
  • Country Composition
  • Commercial Cues
• APAC - Market by End-Use Organization Type
  • Forecast by End-Use Org Type (USD Mill, 2023-32)
  • Headlines
  • Regional Synthesis
  • Source: Marketstrat Estimates & Forecast Model
  • Who Buys Which Category (2032 Split Inside Each End-Use)
  • Commercial Implications
  • APAC Totals by End-Use Org (Rolled-Up; Rounded)
• APAC - Market by AI Technology
  • Forecast by AI Technology (USD Mill, 2023-32)
  • Headlines
  • Regional Synthesis
  • APAC Totals by AI Technology (Rolled-Up; Rounded)
  • Commercial Implications
• APAC - Market by Pathway Stage
  • Forecast by Pathway Stage (USD Mill, 2023-32)
  • Headlines
  • Regional Synthesis
  • Country / Sub-Region Pattern is Strikingly Uniform
  • Market Math (Rounded, APAC Totals)
  • Commercial Implications

SECTION 15 - CHINA

Market Overview and Analysis

• Headline Math (China)
• China - At a Glance (Key Numbers, 2023->2032)
• What's Driving China
  • Demand & Supply Fundamentals
  • Screening Rails (Moving Upstream)
  • Adoption Enablers
• Buyer & Hosting Posture (China-Specific)
• Commercial Playbook - How to Win
• Key Takeaways (China)
• Incidence & Screening - Quick Context (for planning; directional)
• Provider Landscape Snapshot (indicative, GTM-relevant)
• Packaging & Pricing Realities (China)
• Signals to Watch ('25-'28)

China - Market Estimates & Forecasts

• China - Market by Modality (2023-32)
  • Forecast by Modality (USD Mill, 2023-32)
  • Highlights (2023->2032)
  • What's Shifting (Local Market Mechanics)
  • Pricing & Packaging Posture (by Modality)
  • Who Drives the Growth
  • Competitive Lens
  • Signals to Watch
  • Risks
  • Actions (90-day Playbook)
  • Market Math & Diffusion (China, Modality)
• China - Market by Clinical Application
  • Forecast by Clinical Application (USD Mill, 2023-32)
  • Highlights
  • What's Shifting (Local Mechanics)
  • Market Math & Diffusion (China, Clinical Application)
  • Who Drives the Growth
  • Pricing & Packaging (by Application)
  • Competitive Lens
  • Signals to Watch
  • Risks
  • Actions (90-day Playbook)
• China - Market by Tumor Site
  • Forecast by Tumor Site (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Market Math & Diffusion (China, Tumor Site)
  • Who Drives the Growth
  • Pricing & Packaging
  • Competitive Lens
  • Signals to Watch
  • Actions - 90-Day Playbook
• China - Market by Revenue Stream
  • Forecast by Revenue Stream (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Market Math & Diffusion (China, Revenue Stream)
  • Who Drives the Growth
  • Pricing & Packaging
  • Competitive Lens
  • Signals to Watch
  • Actions - 90-Day Playbook
• China - Market by End-Use Organization Type
  • Forecast by End-Use Organization Type (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Market Math & Diffusion (China, End-Use Orgs)
  • Who Drives the Growth
  • Pricing & Packaging
  • Competitive Lens
  • Signals to Watch
  • Risks
  • Actions - 90-Day Playbook
• China - Market by AI Technology (2023-32)
  • Forecast by AI Technology (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Who Drives the Growth
  • Market Math & Diffusion (China, AI Technology)
  • Pricing & Packaging
  • Competitive Lens
  • Signals to Watch
  • Risks
  • Actions - 90-Day Playbook
• China - Market by Pathway Stage (2023-32)
  • Forecast by Pathway Stage (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Who Drives the Growth
  • Market Math & Diffusion (China, Pathway Stage)
  • Pricing & Packaging
  • Competitive Lens
  • Signals to Watch
  • Risks
  • Actions - 90-Day Playbook

SECTION 16 - JAPAN

Market Overview and Analysis

• Headline Math
• Japan - At a Glance
• What's Driving Japan
  • Demand & Supply Fundamentals
  • Screening Rails (Upstream Engines)
  • Adoption Enablers
• Buyer & Hosting Posture (Japan)
• Commercial Playbook - How to Win
• Key Takeaways (Japan)
• Incidence & Screening - Quick Context (Planning Cues)
  • Signals to Watch ('25-'28)
  • Risks

Market Estimates & Forecasts

• Japan - Market by Modality
  • Forecast by Modality (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Who Drives the Growth
  • Pricing & Packaging
  • Market Math & Diffusion (Japan, Modality)
  • Competitive Lens
  • Signals to Watch
  • Risks
  • Actions (90-day playbook)
• Japan - Market by Clinical Application
  • Forecast by Clinical Application (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Who Drives the Growth
  • Market Math & Diffusion (Japan, Clinical Application)
  • Pricing & Packaging
  • Competitive Lens
  • Signals to Watch
  • Actions (90-day Playbook)
• Japan - Market by Tumor Site
  • Forecast by Tumor Site (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Who Drives the Growth
  • Market Math & Diffusion (Japan, Tumor Site)
  • Pricing & Packaging
  • Competitive Lens
  • Signals to Watch
  • Risks
  • Actions (90-day Playbook)
• Japan - Market by Revenue Stream
  • Forecast by Revenue Stream (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Who Drives the Growth
  • Market Math & Diffusion (Japan, Revenue Stream)
  • Pricing & Packaging
  • Actions (90-day Playbook)
• Japan - Market by End-Use Organization Type
  • Forecast by End-Use Organization Type (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Who Drives the Growth
  • Market Math & Diffusion (Japan, End-Use Orgs)
  • Pricing & Packaging
  • Competitive Lens
  • Signals to Watch
  • Actions (90-day Playbook)
• Japan - Market by AI Technology
  • Forecast by AI Technology (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Who Drives the Growth
  • Market Math & Diffusion (Japan, AI Technology)
  • Pricing & Packaging
  • Actions (90-day Playbook)
• Japan - Market by Pathway Stage
  • Forecast by Pathway Stage (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Who Drives the Growth
  • Market Math & Diffusion (Japan, Pathway Stage)
  • Pricing & Packaging
  • Actions (90-day Playbook)

SECTION 17 - INDIA

Market Overview & Dynamics

• Headline Math (India, 2023->2032)
• What's Driving India
  • Demand & Supply Fundamentals
  • Adoption Enablers & Guardrails
  • Buyer & Hosting Posture (India-specific)
  • Commercial Playbook (How to Win)
  • India - At a Glance (Key Numbers, 2023->2032)
  • Three Takeaways
  • Incidence & Screening - Quick Context (for GTM framing)
  • Competitive Lens (indicative, India-relevant Clusters)
  • Packaging & Pricing Realities (India)

Market Estimates & Forecasts

• India - Market by Modality
  • Forecast by Modality (USD Mill, 2023-32)
  • Highlights
  • What's shifting (India-specific)
  • Who Drives the Growth
  • Market Math & Diffusion (India, Modality)
  • Pricing & Packaging (to win in India)
  • Competitive Lens
  • Signals to Watch ('25-'28)
  • Risks
  • 90-Day Actions (Playbook)
• India - Market by Clinical Application
  • Forecast by Clinical Application (USD Mill, 2023-32)
  • Highlights
  • What's Shifting (India-specific)
  • Who Drives the Growth
  • Market Math & Diffusion (India, Clinical Application)
  • Pricing & Packaging (to win in India)
  • Signals to watch ('25-'28)
  • Risks
  • 90-day Playbook
• India - Market by Tumor Site
  • Forecast by Tumor Site (USD Mill, 2023-32)
  • Highlights
  • What's Shifting (India-specific)
  • Who Drives the Growth
  • Market Math & Diffusion (India, Clinical Application)
  • Pricing & Packaging (to win in India)
  • Signals to watch ('25-'28)
  • Risks
  • 90-day Playbook
  • Incidence & Screening - Quick Context (India)
  • Estimated New Cases (2022)
  • Programmatic Screening Rails
• India - Market by Revenue Stream
  • Forecast by Revenue Stream (USD Mill, 2023-32)
  • Highlights
  • What's Shifting (India-specific)
  • Who Drives the Growth
  • Market Math & Diffusion
  • Pricing & packaging (to win in India)
  • Signals to watch ('25-'28)
  • Risks
  • 90-day Playbook
• India - Market by End-Use Organization Type
  • Forecast by End-Use Org Type (USD Mill, 2023-32)
  • Highlights
  • What's shifting (India-specific)
  • Who Drives the Growth
  • Market Math & Diffusion (India, End-Use Orgs)
  • Pricing & Packaging (to win in India)
  • Signals to Watch ('25-'28)
  • 90-day Playbook
• India - Market by AI Technology
  • Forecast by AI Technology (USD Mill, 2023-32)
  • Highlights
  • What's Shifting (India-Specific)
  • Who Drives the Growth
  • Market Math & Diffusion (India, AI Technology)
  • Pricing & Packaging (to win in India)
  • Signals to watch ('25-'28)
  • 90-day Playbook
• India - Market by Pathway Stage - Japan
  • Forecast by Pathway Stage (USD Mill, 2023-32)
  • Highlights
  • What's Shifting (India-specific)
  • Who Drives the Growth
  • Market Math & Diffusion (India, Pathway Stage)
  • Pricing & packaging (to win in India)
  • Signals to watch ('25-'28)
  • 90-day Playbook

SECTION 18 - REST OF ASIA-PACIFIC (ROAPAC)

Market Overview and Analysis

• Headline Math (ROAPAC)
• ROAPAC Clusters (Definitions + Countries)
• What's Driving ROAPAC
  • Demand & Supply Fundamentals
  • Adoption Enablers
• Commercial Playbook (How to Win)
• Pricing & Packaging Truths
• Buyer & Hosting Posture (by Cluster)
• Incidence & Screening - Quick Context Signals
• ROAPAC - At-a-Glance (Key Numbers, 2023->2032)
• Three Takeaways
• Packaging & Pricing Realities
• Evidence, Regulatory & Governance Notes
• Signals to Watch ('25-'28)
• Competitive Lens (Indicative Clusters)

Market Estimates & Forecasts

• ROAPAC - Market by Modality
  • Forecast by Modality (USD Mill, 2023-32)
  • Highlights
  • What's Shifting (by Cluster)
  • Who Drives the Growth ('23->'32)
  • Market Math & Diffusion (ROAPAC, Modality)
  • So-What (Pricing & Packaging)
  • Competitive Lens (Indicative Clusters)
  • Signals to Watch ('25-'28)
  • Risks
• ROAPAC - Market by Clinical Application
  • Forecast by Clinical Application (USD Mill, 2023-32)
  • Highlights
  • What's Shifting (by Cluster)
  • Who Drives the Growth
  • Market Math & Diffusion (ROAPAC, Clinical Application)
  • So-What (Pricing/Packaging)
  • Signals to Watch ('25-'28)
  • Risks
• ROAPAC - Market by Tumor Site
  • Forecast by Tumor Site (USD Mill, 2023-32)
  • Highlights
  • What's Shifting (by Cluster)
  • Market Math & Diffusion (ROAPAC, Tumor Site)
  • Pricing/Packaging
  • Signals to Watch ('25-'28)
  • Risks
  • 90-day Playbook
• ROAPAC - Market by Revenue Stream
  • Forecast by Revenue Stream (USD Mill, 2023-32)
  • Highlights
  • What's Shifting (by Cluster)
  • Who Drives the Growth
  • Market Math & Diffusion (ROAPAC, Revenue Stream)
  • So-What (Pricing/Packaging)
  • Signals to Watch ('25-'28)
  • Risks
  • 90-day Playbook
• ROAPAC - Market by End-Use Organization Type
  • Forecast by End-Use Organization Type (USD Mill, 2023-32)
  • Highlights
  • What's Shifting (by Cluster)
  • Who Drives the Growth
  • Market Math & Diffusion (ROAPAC, End-Use Org)
  • Pricing & Packaging (to win)
  • Signals to watch ('25-'28)
  • Risks
  • 90-day Playbook
• ROAPAC - Market by AI Technology
  • Forecast by AI Technology (USD Mill, 2023-32)
  • Market Math & Diffusion (ROAPAC, AI Technology)
  • Who Drives the Growth ('23->'32)
  • What's Shifting (by Cluster)
  • Pricing & Packaging (to win)
  • Signals to watch ('25-'28)
  • Risks
  • 90-day Playbook
• ROAPAC - Market by Pathway Stage
  • Forecast by Pathway Stage (USD Mill, 2023-32)
  • Highlights
  • What's Shifting (by Cluster)
  • Who Drives the Growth ('23->'32)
  • Market Math & Diffusion (ROAPAC, Pathway Stage)
  • Pricing & Packaging (to win)
  • Signals to Watch ('25-'28)
  • Risks
  • 90-day Playbook

SECTION 19 - LATIN AMERICA (LATAM)

Market Overview and Dynamics

• Headline Math
• What's Driving LATAM (Demand & Supply Fundamentals)
• Cluster Lens (Who Buys, How to Win)
• Buyer & Hosting Posture
• Incidence & Screening - Quick Context (Operational Impact)
• Packaging & Pricing Realities
• Evidence & Regulatory Notes (What Buyers will Ask)
• Competitive Lens (Indicative, LATAM-relevant Clusters)
• LATAM - At-a-Glance (Key Numbers, 2023->2032)
• Three Takeaways
• 90-Day Commercial Playbook (Action)

Market Estimates & Forecasts

• LATAM - Market by Modality
  • Forecast by Modality (USD Mill, 2023-32)
  • Clusters (Definitions & GTM Posture)
  • Highlights
  • What's Shifting (by Cluster)
  • Who Drives the Growth
  • Market Math & Diffusion (LATAM, Modality)
  • Pricing & Packaging (To Win)
  • Competitive Lens (Indicative)
  • Signals to Watch ('25-'28)
  • Risks
  • 90-day Playbook
• LATAM - Market by Clinical Application
  • Forecast by Clinical Application (USD Mill, 2023-32)
  • Clusters (Definitions & GTM Posture)
  • Highlights
  • Who Drives the Growth ('23->'32 Contribution)
  • Market Math & Diffusion (LATAM, Clinical Application)
  • Pricing & Packaging (to win)
  • Signals to Watch ('25-'28)
  • Risks
  • 90-Day Playbook
• LATAM - Market by Tumor Site
  • Forecast by Tumor Site (USD Mill, 2023-32)
  • Clusters (How to Interpret The Tumor Mix)
  • Highlights
  • Who Drives the Growth ('23->'32)
  • Market Math & Diffusion (LATAM, Tumor Site)
  • Pricing & Packaging (to Win)
  • Signals to Watch ('25-'28)
  • Risks
  • 90-Day Playbook
• LATAM - Market by Revenue Stream
  • Forecast by Revenue Stream (USD Mill, 2023-32)
  • Clusters (Definitions & GTM Posture)
  • Highlights
  • Who Drives the Growth ('23->'32 Contribution)
  • Market Math & Diffusion (LATAM, Revenue Stream)
  • Pricing & Packaging (to win)
  • Signals to Watch ('25-'28)
  • Risks
  • 90-Day Playbook
• LATAM - Market by End-Use Organization Type
  • Forecast by End-Use Organization Type (USD Mill, 2023-32)
  • Clusters (Operating Reality & GTM)
  • Highlights
  • Who Drives the Growth ('23->'32)
  • Market Math & Diffusion (LATAM, End-Use Org)
  • Pricing & Packaging (to win)
  • Signals to Watch ('25-'28)
  • Risks
  • 90-Day Playbook
• LATAM - Market by AI Technology
  • Forecast by AI Technology (USD Mill, 2023-32)
  • Clusters (Operating Reality & GTM)
  • Highlights
  • Who Drives the Growth ('23->'32 Contribution)
  • Market Math & Diffusion (LATAM, AI Technology)
  • Pricing & Packaging (to win)
  • Competitive Lens (Indicative)
  • Signals to Watch ('25-'28)
  • Risks
  • 90-Day Playbook
• LATAM - Market by Pathway Stage
  • Forecast by Pathway Stage (USD Mill, 2023-32)
  • Highlights
  • What's Shifting (mix)
  • Who Drives the Growth ('23->'32)
  • Market Math & Diffusion (LATAM, Pathway Stage)
  • Pricing & Packaging (to win)
  • Cluster Lens (Practical GTM)
  • Signals to Watch ('25-'28)
  • Risks
  • 90-Day Playbook

SECTION 20 - MIDDLE EAST & AFRICA (MEA)

Market Overview and Dynamics

• Headline Math
• What's Driving MEA (Demand & Supply Fundamentals)
  • Disease & Activity
  • Capacity & Workforce Reality
  • Screening Rails (High-Signal)
  • Adoption Enablers
• Commercial Playbook by Custer (How To Win)
• MEA - At a Glance
• Buyer & Hosting Posture (What Procurement asks for)
• Incidence & Screening - Quick Context Cues (for GTM Planning)
• Packaging & Pricing Realities
• Evidence & Regulatory Notes
• Signals to Watch ('25-'28)
• Three Takeaways
• MEA - At-a-Glance Card

Market Estimates & Forecasts

• Market by Modality (2023-32)
  • Forecast by Modality (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Who Drives the Growth
  • Market Math & Diffusion (MEA, Modality)
  • Pricing & Packaging - Actionable Posture by Cluster
  • Competitive Lens (Indicative)
  • Signals to Watch ('25-'28)
  • Risks
  • 90-Day GTM Playbook
• Market by Clinical Application
  • Forecast by Clinical Application (USD Mil, 2023-32)
  • Highlights
  • What's Shifting
  • Who Drives the Growth ('23->'32)
  • Market Math & Diffusion (MEA, Clinical Application)
  • So-What (Pricing/Packaging)
  • Competitive Lens (Indicative)
  • Signals to Watch ('25-'28)
  • Risks
  • 90-Day Playbook
• MEA - Market by Tumor Site
  • Forecast by Tumor Site (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Who Drives the Growth ('23->'32)
  • Market Math & Diffusion (MEA, Tumor Site)
  • Pricing & Packaging (to win)
  • Incidence & Screening - Quick Context (operational cues)
  • Competitive Lens (Indicative)
  • Signals to Watch ('25-'28)
  • Risks
  • 90-Day Playbook
• MEA - Market by Revenue Stream
  • Forecast by Revenue Stream (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Who Drives the Growth ('23->'32)
  • Market Math & Diffusion (MEA, Revenue Stream)
  • Pricing & Packaging (how to win)
  • Competitive Lens (indicative)
  • Signals to Watch ('25-'28)
  • Risks
  • 90-Day Playbook
• MEA - Market by End-Use Organization Type
  • Forecast by End-Use Organization Type (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Who Drives the Growth ('23->'32)
  • Market Math & Diffusion (MEA, End-Use Org Type)
  • Pricing & Packaging (how to win)
  • Signals to Watch ('25-'28)
  • Risks
  • 90-Day Playbook
• MEA - Market by AI Technology
  • Forecast by AI Technology (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Who Drives the Growth ('23->'32)
  • Market Math & Diffusion (MEA, AI Technology)
  • Pricing & Packaging (how to win)
  • Competitive Lens (indicative)
  • Signals to Watch ('25-'28)
  • Risks
  • 90-Day Playbook
• MEA - Market by Pathway Stage
  • Forecast by Pathway Stage (USD Mill, 2023-32)
  • Highlights
  • What's Shifting
  • Who Drives the Growth ('23->'32)
  • Market Math & Diffusion (MEA, Pathway Stage)
  • Pricing & Packaging (how to win)
  • Competitive Lens (indicative)
  • Signals to Watch ('25-'28)
  • Risks
  • 90-Day Playbook